On Tuesday, Atricure Inc (NASDAQ: ATRC) opened higher 4.03% from the last session ,before settling in for the closing price of $26.54. Price fluctuations for ATRC have ranged from $25.83 to $59.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15.61% annually for the last half of the decade. Company’s average yearly earnings per share was noted -10.42% at the time writing. With a float of $46.71 million, this company’s outstanding shares have now reached $47.53 million.
In an organization with 1200 employees, it is important to assess its efficiency.
Atricure Inc (ATRC) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Atricure Inc is 3.45%, while institutional ownership is 97.89%. The most recent insider transaction that took place on Apr 01 ’24, was worth 45,585. In this transaction Chief Mktg & Strategy Officer of this company sold 1,500 shares at a rate of $30.39, taking the stock ownership to the 72,784 shares. Before that another transaction happened on Mar 18 ’24, when Company’s Chief Legal Officer sold 1,885 for $32.16, making the entire transaction worth $60,622. This insider now owns 50,954 shares in total.
Atricure Inc (ATRC) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/30/2023, the company posted -$0.21 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.23) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to -1.17% drop over the previous five years of trading.
Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators
Check out the current performance indicators for Atricure Inc (ATRC). In the past quarter, the stock posted a quick ratio of 2.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Atricure Inc (ATRC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.81 million. That was better than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.49%. Additionally, its Average True Range was 1.32.
During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 10.37%, which indicates a significant decrease from 32.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.44% in the past 14 days, which was higher than the 49.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.42, while its 200-day Moving Average is $39.71. However, in the short run, Atricure Inc’s stock first resistance to watch stands at $27.99. Second resistance stands at $28.38. The third major resistance level sits at $29.12. If the price goes on to break the first support level at $26.86, it is likely to go to the next support level at $26.12. Assuming the price breaks the second support level, the third support level stands at $25.73.
Atricure Inc (NASDAQ: ATRC) Key Stats
There are currently 48,375K shares outstanding in the company with a market cap of 1.34 billion. Presently, the company’s annual sales total 399,250 K according to its annual income of -30,440 K. Last quarter, the company’s sales amounted to 106,540 K and its income totaled -9,790 K.
